BeStock  

Solventum SOLV

US equityMarket cap rank #684Medical Instruments & Supplies
$87.03 −$1.12 (-1.27%)
Market open · Oct 1, 11:50 am ET · After hours $88.15 0.00%
Open$87.87
Prev close$88.15
Day range$86.67 – $88.55
Volume116.3K
Market cap$14.81B
P/E (TTM)10.6
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$2.21B+2.2% YoY
Operating profit$181.00M-15.4% YoY
Net profit$93.00M+3.3% YoY
Diluted EPS$0.53+3.9% YoY
Free cash flow$144.00M+144.1% YoY
Operating cash flow$227.00M

Revenue, last 8 quarters

$2.1BSep '24$2.1BDec '24$2.1BMar '25$2.2BJun '25$2.1BSep '25$2.0BDec '25$2.0BMar '26$2.2BJun '26

Net profit, last 8 quarters

$122.0MSep '24$30.0MDec '24$137.0MMar '25$90.0MJun '25$1.3BSep '25$63.0MDec '25$13.0MMar '26$93.0MJun '26

Diluted EPS by quarter

0.70Sep '240.17Dec '240.78Mar '250.51Jun '257.22Sep '250.36Dec '250.07Mar '260.53Jun '26

Free cash flow by quarter

$76.0MSep '24$92.0MDec '24$-80.0MMar '25$59.0MJun '25$-21.0MSep '25$32.0MDec '25$-273.0MMar '26$144.0MJun '26

Annual revenue

$7.3BFY20$8.2BFY21$8.1BFY22$8.2BFY23$8.3BFY24$8.3BFY25

Profitability & balance sheet

Gross margin54.7%
Operating margin6.3%
Net margin17.3%
Return on equity34.0%
Return on assets9.8%
Return on invested capital15.0%
Current ratio1.02
Liabilities / assets66.3%
Cash & investments$403.00M
Total debt$5.29B
Net cash (debt)-$4.88B

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $2.21B $2.01B $8.33B $2.00B $2.10B
Total Operating Revenue $2.21B $2.01B $8.33B $2.00B $2.10B
Cost of Revenue $923.00M $911.00M $3.87B $971.00M $961.00M
Gross Profit $1.29B $1.10B $4.45B $1.03B $1.14B
Operating Expense $1.11B $1.02B $3.82B $934.00M $963.00M
Selling and Admin Expenses $927.00M $827.00M $3.08B $759.00M $780.00M
Research & Development $178.00M $189.00M $739.00M $175.00M $183.00M
Operating Profit $181.00M $79.00M $632.00M $93.00M $172.00M
Net Non-Operating Interest Income (Expense) -$64.00M -$62.00M -$347.00M -$51.00M -$89.00M
Non-Operating Interest Expense $64.00M $62.00M $347.00M $51.00M $89.00M
Other Income (Expense) -$9.00M -$4.00M $1.43B $16.00M $1.43B
Other Non-Operating Income (Expenses) -$9.00M -$4.00M -$39.00M -$15.00M -$5.00M
Pretax Profit $108.00M $16.00M $1.71B $58.00M $1.51B
Tax $15.00M $3.00M $157.00M -$5.00M $248.00M
Net Profit $93.00M $13.00M $1.56B $63.00M $1.27B
Profit from Continuing Operations $93.00M $13.00M $1.56B $63.00M $1.27B
Net Income to Parent Company $92.00M $13.00M $1.56B $63.00M $1.27B
Net Income to Common Stockholders $92.00M $13.00M $1.56B $63.00M $1.27B
Basic EPS $0.53 $0.07 $8.94 $0.36 $7.26
Diluted EPS $0.53 $0.07 $8.88 $0.36 $7.22
Special Income (Charges) – – $1.47B $31.00M $1.44B
-Less:Other Special Charges – – $82.00M $0.00 $82.00M
-Gain on Sale Of Business – – $1.55B $31.00M $1.52B

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $14.24B $14.10B $14.29B $14.29B $13.97B
Total Current Assets $3.74B $3.58B $3.86B $3.86B $4.41B
Cash and Cash Equivalents & Short-Term Investments $403.00M $561.00M $878.00M $878.00M $1.64B
-Cash and Cash Equivalents $403.00M $561.00M $878.00M $878.00M $1.64B
Receivables $1.43B $1.18B $1.18B $1.18B $1.18B
-Accounts Receivable $1.31B $1.06B $1.03B $1.03B $1.02B
-Due from Related Parties Current $122.00M $121.00M $150.00M $150.00M $157.00M
Prepaid Assets $205.00M $187.00M $174.00M $174.00M –
Inventory $1.04B $1.09B $1.07B $1.07B $1.05B
Other Current Assets $661.00M $566.00M $557.00M $557.00M $540.00M
Total Non-Current Assets $10.50B $10.52B $10.44B $10.44B $9.57B
Net PPE $1.75B $1.73B $1.33B $1.33B $1.34B
-Gross PPE $3.64B $3.60B $3.19B $3.19B $3.18B
-Accumulated Depreciation -$1.89B -$1.87B -$1.87B -$1.87B -$1.84B
Goodwill and Other Intangible Assets $8.03B $8.12B $8.30B $8.30B $7.48B
-Goodwill $5.63B $5.63B $5.70B $5.70B $5.26B
-Other Intangible Assets $2.41B $2.50B $2.59B $2.59B $2.22B
Non-Current Deferred Assets $344.00M $303.00M – – –
Other Non-Current Assets $372.00M $359.00M $814.00M $814.00M $747.00M
Total Liabilities $9.44B $9.13B $9.24B $9.24B $8.99B
Total Current Liabilities $3.66B $3.35B $3.14B $3.14B $2.94B
Payables $1.21B $1.21B $1.32B $1.32B $1.35B
-Accounts Payable $701.00M $699.00M $687.00M $687.00M $669.00M
-Total Tax Payable $176.00M $170.00M $196.00M $196.00M $212.00M
-Due to Related Parties Current $331.00M $337.00M $435.00M $435.00M $464.00M
Current Accrued Expenses $295.00M $209.00M $243.00M $243.00M $212.00M
Short-Term Debt and Capital Lease Obligation $506.00M $505.00M – – –
-Current Debt $506.00M $505.00M – – –
Current Deferred Liabilities $596.00M $613.00M $621.00M $621.00M $576.00M
Other Current Liabilities $841.00M $646.00M $634.00M $634.00M $546.00M
Total Non-Current Liabilities $5.78B $5.78B $6.11B $6.11B $6.05B
Long Term Debt and Capital Lease Obligation $4.78B $4.78B $5.04B $5.04B $5.14B
-Long Term Debt $4.57B $4.58B $5.04B $5.04B $5.14B
-Long Term Capital Lease Obligation $207.00M $207.00M – – –
Non-Current Deferred Liabilities $157.00M $161.00M $164.00M $164.00M $169.00M
Employee Benefits $358.00M $360.00M $363.00M $363.00M $306.00M
Other Non-Current Liabilities $486.00M $478.00M $546.00M $546.00M $437.00M
Total Equity $4.80B $4.97B $5.05B $5.05B $4.99B
Stockholders' Equity $4.80B $4.97B $5.05B $5.05B $4.99B
Capital Stock $2.00M $2.00M $2.00M $2.00M $2.00M
-Common Stock $2.00M $2.00M $2.00M $2.00M $2.00M
Additional Paid-In Capital $3.92B $3.90B $3.88B $3.88B $3.85B
Retained Earnings $1.90B $1.81B $1.80B $1.80B $1.73B
Less: Treasury Stock $355.00M $67.00M – – –
Gains/Losses Not Affecting Retained Earnings -$669.00M -$670.00M -$625.00M -$625.00M -$604.00M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $227.00M -$189.00M $369.00M $95.00M $76.00M
Net cash flow from continuing operations $224.00M -$188.00M $369.00M $95.00M $76.00M
Net Income from Continuing Operations $92.00M $13.00M $1.56B $63.00M $1.27B
Gain/Loss from Continuing Operations $13.00M $14.00M -$1.49B -$18.00M -$1.50B
Depreciation & Depletion & Amortization $133.00M $135.00M $489.00M $117.00M $121.00M
Deferred Tax -$47.00M -$41.00M -$120.00M -$73.00M $130.00M
Other Non-Cash Items $3.00M -$1.00M -$111.00M -$25.00M –
Change in Working Capital -$5.00M -$360.00M -$119.00M -$6.00M $105.00M
-Change in Receivables -$253.00M -$6.00M $78.00M $5.00M $84.00M
-Change in Inventory $50.00M -$32.00M -$139.00M -$5.00M -$57.00M
-Change in Payables and Accrued Expense $36.00M -$228.00M $136.00M $53.00M $113.00M
-Change In Other Working Capital $162.00M -$94.00M -$194.00M -$59.00M -$35.00M
Net cash flow from investing -$87.00M -$77.00M $2.80B -$745.00M $3.77B
Net Cash Flow from Continuing Investing Activities -$87.00M -$77.00M $2.80B -$745.00M $3.77B
Net PPE Purchase and Sale -$83.00M -$84.00M -$379.00M -$63.00M -$97.00M
Net Other Investing Changes -$4.00M $7.00M -$18.00M -$6.00M -$7.00M
Financing Cash Flow -$300.00M -$50.00M -$3.06B -$115.00M -$2.69B
Net Cash Flow from Continuing Financing Activities -$301.00M -$50.00M -$3.06B -$115.00M -$2.69B
Net Issuance Payments Of Debt $0.00 $46.00M -$3.07B -$100.00M -$2.77B
Net Common Stock Issuance -$288.00M -$67.00M – – –
Net Other Financing Charges -$12.00M -$29.00M $13.00M -$15.00M $77.00M
Ending Cash Balance $403.00M $561.00M $878.00M $878.00M $1.64B
Net Change in Cash -$161.00M -$315.00M $109.00M -$765.00M $1.15B
Beginning Cash Balance $561.00M $878.00M $762.00M $1.64B $492.00M
Effect of Exchange Rate Changes $3.00M -$2.00M $7.00M $1.00M -$1.00M
Free Cash Flow $144.00M -$273.00M -$10.00M $32.00M -$21.00M
Net Business Purchase and Sale – – $3.19B -$676.00M –

Discussion

No comments yet — be the first to weigh in on SOLV.

Leave a comment

Scroll to Top